CEO Video: Stephen Wilson, Genus*


In these five videos Genus's CEO designate, Stephen Wilson, gives an update on African Swine Fever in China and how it's affecting Genus’s business, how the gene-editing R&D programme is progressing, what drove the 42% sexed semen volume growth in FY2019 and can it continue and what are his priorities for his first twelve months as CEO. Click below to read the latest research. 

Robust FY2019 results, nudging TP up to 2800p - 05.09.19

PRRSv-resistance for China - 16.05.19

Beefing up the growth outlook - 05.03.19

*The views in these videos are those of Stephen Wilson, designate CEO of Genus. Genus are a corporate client of Liberum.

This communication is for use only by a person or entity that qualifies as a "Professional Client" or "Eligible Counterparty" within the meaning of the FCA's rules. It is therefore intended for use only by persons having professional experience in matters relating to investments. Any other person who receives this should not act on the contents. Disclaimer here

New York

Our offices


Ropemaker Place, Level 12 25 Ropemaker Street London EC2Y 9LY

New York

20th Floor 575 Fifth Avenue New York NY 10017